Biomarkers and Precision Medicine Community (BPMC)

Please join us for an Open Scientific Discussion (OSD) hosted by the Biomarkers and Precision Medicine (BPM) Community on July 9, from 1-2 PM ET on the following topic:

Multi-Parametric Biomarker Signatures

• How do we go from identifying a potential biomarker with omics tools to an assay that is used in clinical trials?
• Examples of biomarker panel assay use:  Renal safety biomarkers, Alzheimer’s disease, pharmacodynamic signatures
• Challenges in establishing and translating multi-parameter biomarker assays to the clinic

Discussion Leaders:

Tom Lanz (Pfizer)

Tim West (C2N Diagnostics)

Chris Whelan (formerly Johnson & Johnson)

Organized by:  

Joel Matthews (Ionis Pharmaceuticals)

Jurre Kamphorst (AstraZeneca)

Carmen Fernández-Metzler (PharmaCadence Analytical Services)

Karen Quadrini (Prothena Biosciences)

We start at 1:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

(Please remain on mute unless asking questions)

When: Wednesday July 9, 2025, 1 pm – 2 pm ET

Where: Please join from your computer, tablet or smartphone.

Microsoft Teams Need help?

Join the meeting now

Meeting ID: 279 600 469 385 3

Passcode: jg3oC6Uj

Please feel free to share with colleagues who may be interested in this topic. Thank you!

The AAPS BPM Community Leadership Team